Literature DB >> 6305848

Cefotaxime and desacetyl cefotaxime in human bile.

F Kees, E Strehl, P Dominiak, H Grobecker, K Seeger, G Seidel, B Neuhaus, L Safrany.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6305848     DOI： 10.1007/bf01641077

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  14 in total

1.  [Biliary elimination of cefazedon].

Authors:  P Kratochvil; G Brandstätter; D Adam; E Koch
Journal:  MMW Munch Med Wochenschr       Date:  1979-04-06

2.  Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo).

Authors:  E Schrinner; M Limbert; L Penasse; A Lutz
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

3.  Human metabolism of cefotaxime.

Authors:  D S Reeves; L O White; H A Holt; D Bahari; M J Bywater; R P Bax
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

4.  The biliary tract kinetics of some cephalosporin antibiotics.

Authors:  L Trachtenberg; K M Fagelman; H C Polk
Journal:  Surgery       Date:  1978-09       Impact factor: 3.982

5.  Cefoperazone: absorption, excretion, distribution, and metabolism.

Authors:  K Shimizu
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

6.  Biliary excretion and tissue levels of cefuroxime. A study in eleven patients undergoing cholecystectomy.

Authors:  M Severn; S J Powis
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

7.  Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum.

Authors:  M R Keighley; R B Drysdale; A H Quoraishi; D W Burdon; J Alexander-Willians
Journal:  Gut       Date:  1976-07       Impact factor: 23.059

8.  Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins.

Authors:  R Wise; P J Wills; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

9.  Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatography.

Authors:  F Kees; E Strehl; K Seeger; G Seidel; P Dominiak; H Grobecker
Journal:  Arzneimittelforschung       Date:  1981

10.  [Investigations on the excretion of cefaclor in human bile (author's transl)].

Authors:  O Müller; U Rückert; K Fabricius
Journal:  Infection       Date:  1979       Impact factor: 3.553
View more
  6 in total

1.  Penetration of cefazolin, ceftriaxone, cefoperazone, and ceftazidime into human gallbladder tissue and bile.

Authors:  S A Berger; Y Levy; A Halevy; A Gorea; R Orda
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

2.  Pharmacokinetics and clinical study of cefotetan in bile: prophylactic use in biliary tract surgery.

Authors:  P Cherrier; P Perrin; S Gueye; A M Bosio; P Tinel; P Blot; R Richer; F Fauvelle
Journal:  Pharm World Sci       Date:  1993-04-23

3.  Biliary excretion of aztreonam in patients with biliary tract disease.

Authors:  O V Martinez; J U Levi; R G Devlin
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

4.  Investigation of the biliary clearances of cefotaxime and desacetylcefotaxime by an original procedure in cholecystectomised patients.

Authors:  F Jehl; J D Peter; A Picard; J P Dupeyron; J Marescaux; A Sibilly; H Monteil
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

Review 5.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 6.  Emergence of vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.